12/16/2024 3:16 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Patrick Donald Huntley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2024 1:58 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Frost Gamma Investments Trust (Reporting) FROST PHILLIP MD ET AL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2024 11:10 AM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Frost Gamma Investments Trust (Reporting) FROST PHILLIP MD ET AL (Reporting)
| Form 4/A | |
12/06/2024 11:11 AM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Patrick Donald Huntley (Reporting)
| Form 4/A | |
12/06/2024 11:12 AM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4/A | |
12/06/2024 11:13 AM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4/A | |
12/04/2024 1:33 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
12/04/2024 1:35 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Patrick Donald Huntley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2024 1:37 PM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2024 1:43 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Frost Gamma Investments Trust (Reporting) FROST PHILLIP MD ET AL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/03/2024 4:49 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) GEYGAN JAMES (Reporting) GEYGAN JEFFREY RICHART (Reporting) Geygan Kathleen (Reporting) GLOBAL VALUE INVESTMENT CORP. (Reporting) Rice Shawn G (Reporting) Wilke Stacy (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/03/2024 4:15 PM | Cogent Biosciences (Subject) Fluent, Inc. (Subject) GLOBAL VALUE INVESTMENT CORP. (Filed by)
| Form SC 13D/A | |
12/02/2024 5:40 AM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 424B5 | |
12/02/2024 5:03 AM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/15/2024 3:32 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form NT 10-Q | |
11/15/2024 3:30 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
09/11/2024 4:36 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Perfit Ryan MacNab (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2024 1:26 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/09/2024 11:15 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form EFFECT | |
08/27/2024 8:00 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
08/26/2024 4:18 PM | Cogent Biosciences (Subject) Fluent, Inc. (Subject) FROST PHILLIP MD ET AL (Filed by)
| Form SC 13D/A | |
08/23/2024 3:35 PM | Cogent Biosciences (Subject) Fluent, Inc. (Subject) Schulke Ryan (Filed by)
| Form SC 13D/A | |
08/23/2024 3:36 PM | Conlin Matthew (Filed by) Cogent Biosciences (Subject) Fluent, Inc. (Subject)
| Form SC 13D/A | |
08/21/2024 1:24 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Frost Gamma Investments Trust (Reporting) FROST PHILLIP MD ET AL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2024 10:59 AM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2024 11:01 AM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Patrick Donald Huntley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2024 11:03 AM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2024 11:04 AM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Perfit Ryan MacNab (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2024 11:20 AM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 10-Q/A | |
08/19/2024 4:13 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/19/2024 3:27 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/15/2024 4:01 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form NT 10-Q | |
07/22/2024 3:52 PM | Cogent Biosciences (Subject) Fluent, Inc. (Subject) Schulke Ryan (Filed by)
| Form SC 13D/A | |
07/17/2024 5:20 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Patrick Donald Huntley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/17/2024 4:00 PM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/11/2024 11:40 AM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/08/2024 2:49 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/08/2024 2:51 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Frost Gamma Investments Trust (Reporting) FROST PHILLIP MD ET AL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2024 11:15 AM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Patrick Donald Huntley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 9:06 AM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) SHATTUCK KOHN BARBARA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 9:10 AM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Mathis Donald H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
"X-Ray Vision" could find thousands of hidden market opportunities (Ad) Let me show you how I trade with “X-Ray vision.”
You see, most “trend” traders only use one trend filter when looking for an optimal buy signal.
And that can be a big mistake because you can’t see if you’re in a “True Trend.”
But my newest trading tool is designed to only target the best, most stable stocks…
Using 3 trend filters… which are these green, yellow, and red lines. Just tap here to join the presentation. |
07/02/2024 9:13 AM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Graff David Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 9:15 AM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) PFENNIGER RICHARD C JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2024 7:53 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Patrick Donald Huntley (Reporting)
| Form 4/A | |
07/01/2024 7:54 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Patrick Donald Huntley (Reporting)
| Form 4/A | |
07/01/2024 7:55 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Patrick Donald Huntley (Reporting)
| Form 4/A | |
07/01/2024 7:56 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Patrick Donald Huntley (Reporting)
| Form 4/A | |
07/01/2024 7:57 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Patrick Donald Huntley (Reporting)
| Form 4/A | |
07/01/2024 7:45 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Patrick Donald Huntley (Reporting)
| Form 4/A | |
06/18/2024 3:43 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 11:14 AM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form DEFA14A | |
06/07/2024 10:35 AM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/04/2024 4:27 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form DEF 14A | |
05/30/2024 3:45 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form D Notice of Exempt Offering of Securities | |
05/23/2024 4:19 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form PRE 14A | |
05/20/2024 4:28 PM | Cogent Biosciences (Subject) Fluent, Inc. (Subject) FROST PHILLIP MD ET AL (Filed by)
| Form SC 13D/A | |
05/16/2024 7:02 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Patrick Donald Huntley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 11:21 AM | Cogent Biosciences (Subject) Fluent, Inc. (Subject) Schulke Ryan (Filed by)
| Form SC 13D/A | |
05/16/2024 11:22 AM | Conlin Matthew (Filed by) Cogent Biosciences (Subject) Fluent, Inc. (Subject)
| Form SC 13D/A | |
05/15/2024 8:55 PM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 8:30 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Frost Gamma Investments Trust (Reporting) FROST PHILLIP MD ET AL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 3:50 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/15/2024 3:18 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/30/2024 4:22 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/29/2024 4:21 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form ARS | |
04/02/2024 3:21 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2024 4:18 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/14/2024 5:01 PM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2024 4:57 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 5:16 PM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 5:17 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 5:26 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Perfit Ryan MacNab (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 8:43 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 8:40 PM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 4:41 PM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 4:43 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:23 PM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:24 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Patrick Donald Huntley (Reporting)
| Form 4/A | |
03/06/2024 5:25 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:25 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Perfit Ryan MacNab (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 11:05 AM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 4:51 PM | Cogent Biosciences (Subject) Fluent, Inc. (Subject) JB CAPITAL PARTNERS LP (Filed by)
| Form SC 13G/A | |
02/12/2024 3:54 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form DEF 14A | |
02/08/2024 9:30 AM | Cogent Biosciences (Subject) Fluent, Inc. (Subject) WELLINGTON TRUST Co N A (Filed by)
| Form SC 13G/A | |
02/01/2024 3:50 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form PRE 14A | |
01/19/2024 3:36 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/29/2023 2:32 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/28/2023 3:05 PM | Cogent Biosciences (Subject) Fluent, Inc. (Subject) GLOBAL VALUE INVESTMENT CORP. (Filed by)
| Form SC 13D/A | |
12/18/2023 4:57 PM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 4:58 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |